Empyrean Healthcare Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
as on 15-11-2024
- Paid Up Capital ₹ 0.10 M
as on 15-11-2024
- Company Age 8 Year, 9 Months
- Last Filing with ROC 31 Mar 2024
- Revenue -32.48%
(FY 2023)
- Profit 8.57%
(FY 2023)
- Ebitda 77.35%
(FY 2023)
- Net Worth 62.65%
(FY 2023)
- Total Assets 13.06%
(FY 2023)
About Empyrean Healthcare
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Anant Kulkarni, Nana Mhaske, Aparna Arun, and One other member serve as directors at the Company.
- CIN/LLPIN
U74120MH2016PTC274562
- Company No.
274562
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
17 Mar 2016
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Mumbai, Maharashtra, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Empyrean Healthcare?
Board Members(4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Anant Kulkarni  | Director | 17-Mar-2016 | Current |
| Nana Mhaske | Director | 17-Mar-2016 | Current |
| Aparna Arun | Director | 17-Mar-2016 | Current |
| Amol Morale | Director | 17-Mar-2016 | Current |
Financial Performance of Empyrean Healthcare.
Empyrean Healthcare Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 32.48% decrease. The company also saw a slight improvement in profitability, with a 8.57% increase in profit. The company's net worth Soared by an impressive increase of 62.65%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Empyrean Healthcare?
In 2023, Empyrean Healthcare had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Krishival Foods LimitedActive 10 years 9 monthsAnant Kulkarni, Nana Mhaske and 1 more are mutual person
Empyrean Speciality Sugar And Biomass LimitedActive 15 years 9 monthsAnant Kulkarni, Nana Mhaske and 1 more are mutual person
- Crazy Talkies Entertainment Private LimitedActive 16 years 11 months
Anant Kulkarni and Nana Mhaske are mutual person
- Siddhivinayak Cashew Industries Private LimitedActive 3 years 2 months
Nana Mhaske and Aparna Arun are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Empyrean Healthcare?
Unlock and access historical data on people associated with Empyrean Healthcare, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Empyrean Healthcare, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Empyrean Healthcare's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
